President Good Brain Just Told the Same Lie for the 80th

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
236
President Good Brain Just Told the Same Lie for the 80th Time

It feels like it should be a bigger story that the world's most powerful man is nuts.

By Jack Holmes
Aug 14, 2019



President Trump Visits Shell Pennsylvania Petrochemicals Complex
Jeff Swensen / Getty Images


It pretty much says it all that there was another Presidential Episode on Tuesday and it was barely a blip on the radar. These spectacles, where the world's most powerful man rants and raves like a guy with whom you'd studiously avoid eye contact on public transportation, happen so regularly that nobody even much remarks on it anymore.

Just a fact of American life. Oh, that's just the president again! You see, Mr. Good Brain went to Pennsylvania yesterday to give a speech that was purportedly on the topic of energy, but which swiftly devolved into a festival of personal grievance and kaleidoscopic delusion. So the usual.


Thanks to CNN's Daniel Dale, we know the president said he's set to lose $5 billion because of lawsuits against him, an amount of money he almost certainly does not have. He demanded that Barack Obama's book deal be investigated, because reasons.

He said China does not have oil and gas—no need to look that one up—and that we'd be begging China for steel (he used a whiny voice) if he hadn't saved the American steel industry, which would be dead without him.

He said the only thing we export to Japan is wheat, which they buy out of pity, all of which is entirely made up and totally bizarre.

He used a racist slur to refer to a presidential candidate. He mocked the idea of computer manufacturing, suggesting people want to dig coal or make steel. He invited the workers in attendance to troll the media with tweets about how he should serve a third or fourth term. He talked about copper theft. He talked about how he's always loved trucks.


TRUMP: “I love cranes, I love trucks of all types. Even when I was a little boy at 4 years old, my mother would say, ‘You love trucks.’ I do."

https://www.esquire.com/news-politics/a286979...n=17783711

— JM Rieger (@RiegerReport) August 13, 2019

The brain, it is good. It was even gooder when he expressed amazement at the turnout for an 11 o'clock speech when it was, in fact, 2:40 p.m.

But the really reassuring stuff came via the insane lying. As a champion bullshitter, Donald Trump is quite adept at convincing himself of something as he makes it up with the intent of convincing others.

The truth is whatever you can get enough people to believe, including yourself. And it appears that the president has thoroughly convinced himself that he is responsible for a program that was signed into law in 2014.

"I got it approved. Veterans Choice," Trump says, for more than the 80th time, of the program signed into law by Obama in 2014.
— Daniel Dale (@ddale8) August 13, 2019


As a refresher, Trump was not president in 2014.

His political career was primarily contained to suggesting the first black president was actually Kenyan, and thus illegitimate. (Not a racist bone in his body, etc. etc.) But the really astounding thing is he's told this lie 80 (eighty!) times and shows no sign of slowing down. He is an unstoppable force of fabrication, and The Lamestream Liberal Fake News Media has not exactly proven itself to be an immovable object. At some point, he says the same false thing so many times that people just give up.

More than the specific lies, though, the establishment media has fought like hell to pretend that Donald Trump is merely an exceptionally rude and eccentric president, rather than someone who is quite clearly unstable and who poses grave danger to the republic.

The President of the United States regularly claims that windmills cause cancer, and some in the press just shrug. They ask him about North Korea's nuclear escalation after his supposed Artful Dealmaking with the regime, and he rants about the Beautiful, Three-Page Letter that Kim Jong-un sent him. Meanwhile, they keep firing off rockets.

This is insanity. It's not Biased for the media to say so, it's fucking reality. Even the Mooch is saying it. Remember that guy? That was crazy, too. Jesus.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading